Differential Use of the C-Type Lectins L-SIGN and DC-SIGN for Phlebovirus Endocytosis

Traffic

Volumn 17, Issue 6, 2016, Pages 639-656

  Léger, Psylvia ^a   Tetard, Marilou ^b,c   Youness, Berthe ^a,b   Cordes, Nicole ^a   Rouxel, Ronan N ^b,d   Flamand, Marie ^e   Lozach, Pierre Yves ^a,b  

^a UNIVERSITY HOSPITAL HEIDELBERG   (Germany)

^b INRS INSTITUT ARMAND FRAPPIER   (Canada)

^c hôpital Robert Debré et Institut national de la transfusion sanguine   (France)

^d INRA Institut National de la Recherche Agronomique   (France)

^e INSTITUT PASTEUR   (France)

Author keywords

Binding; Bunyavirus; C type lectins; CD209; CD209L; DC SIGN; DC SIGNR; Endocytic motif; Endocytosis; L SIGN; Phlebovirus; Rift Valley fever virus; Uptake; Uukuniemi virus; Virus receptor

Indexed keywords

BAFILOMYCIN A1; CD209 ANTIGEN; L SIGN PROTEIN; LECTIN; LYMPHOCYTE ANTIGEN; UNCLASSIFIED DRUG; CELL ADHESION MOLECULE; CELL SURFACE RECEPTOR; CLEC4M PROTEIN, HUMAN; DC-SPECIFIC ICAM-3 GRABBING NONINTEGRIN; PROTEIN BINDING;

ARTICLE; CONTROLLED STUDY; DENDRITIC CELL; ENDOCYTOSIS; ENDOTHELIUM CELL; FLOW CYTOMETRY; FLUORESCENCE MICROSCOPY; HELA CELL LINE; HUMAN; HUMAN CELL; NONHUMAN; PHLEBOVIRUS; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAJI CELL LINE; RIFT VALLEY FEVER; RIFT VALLEY FEVER VIRUS; SIGNAL TRANSDUCTION; TOSCANA VIRUS; UUKUNIEMI VIRUS; VIRUS ATTACHMENT; VIRUS ENTRY; VIRUS PARTICLE; CYTOLOGY; GENETICS; LIVER; METABOLISM; PATHOGENICITY; PHYSIOLOGY; VIROLOGY;

CELL ADHESION MOLECULES; ENDOCYTOSIS; ENDOTHELIAL CELLS; HELA CELLS; HUMANS; LECTINS, C-TYPE; LIVER; PHLEBOVIRUS; PROTEIN BINDING; RECEPTORS, CELL SURFACE; VIRUS INTERNALIZATION;

EID: 84963967657     PISSN: 13989219     EISSN: 16000854     Source Type: Journal    
DOI: 10.1111/tra.12393     Document Type: Article

References (50)

1. Leger P, Lozach PY. Bunyaviruses: from transmission by arthropods to virus entry into the mammalian host first-target cells. Future Virol 2015;10:859-881.
2. Freiberg AN, Sherman MB, Morais MC, Holbrook MR, Watowich SJ. Three-dimensional organization of Rift Valley fever virus revealed by cryoelectron tomography. J Virol 2008;82:10341-10348.
3. Overby AK, Pettersson RF, Grunewald K, Huiskonen JT. Insights into bunyavirus architecture from electron cryotomography of Uukuniemi virus. Proc Natl Acad Sci USA 2008;105:2375-2379.
4. Lozach PY, Huotari J, Helenius A. Late-penetrating viruses. Curr Opin Virol 2011;1:35-43.
5. Lozach PY, Mancini R, Bitto D, Meier R, Oestereich L, Overby AK, Pettersson RF, Helenius A. Entry of bunyaviruses into mammalian cells. Cell Host Microbe 2010;7:488-499.
6. Lozach PY, Kuhbacher A, Meier R, Mancini R, Bitto D, Bouloy M, Helenius A. DC-SIGN as a receptor for phleboviruses. Cell Host Microbe 2011;10:75-88.
7. Nfon CK, Marszal P, Zhang S, Weingartl HM. Innate immune response to Rift Valley fever virus in goats. PLoS Negl Trop Dis 2012;6:e1623.
8. Peyrefitte CN, Perret M, Garcia S, Rodrigues R, Bagnaud A, Lacote S, Crance JM, Vernet G, Garin D, Bouloy M, Paranhos-Baccala G. Differential activation profiles of Crimean-Congo hemorrhagic fever virus- and Dugbe virus-infected antigen-presenting cells. J Gen Virol 2010;91:189-198.
9. Connolly-Andersen AM, Douagi I, Kraus AA, Mirazimi A. Crimean-Congo hemorrhagic fever virus infects human monocyte-derived dendritic cells. Virology 2009;390:157-162.
10. McElroy AK, Nichol ST. Rift Valley fever virus inhibits a pro-inflammatory response in experimentally infected human monocyte derived macrophages and a pro-inflammatory cytokine response may be associated with patient survival during natural infection. Virology 2012;422:6-12.
11. Hofmann H, Li X, Zhang X, Liu W, Kuhl A, Kaup F, Soldan SS, Gonzalez-Scarano F, Weber F, He Y, Pohlmann S. Severe fever with thrombocytopenia virus glycoproteins are targeted by neutralizing antibodies and can use DC-SIGN as a receptor for pH-dependent entry into human and animal cell lines. J Virol 2013;87:4384-4394.
12. Gommet C, Billecocq A, Jouvion G, Hasan M, Zaverucha do Valle T, Guillemot L, Blanchet C, van Rooijen N, Montagutelli X, Bouloy M, Panthier JJ. Tissue tropism and target cells of NSs-deleted rift valley fever virus in live immunodeficient mice. PLoS Negl Trop Dis 2011;5:e1421.
13. Madani TA, Al-Mazrou YY, Al-Jeffri MH, Mishkhas AA, Al-Rabeah AM, Turkistani AM, Al-Sayed MO, Abodahish AA, Khan AS, Ksiazek TG, Shobokshi O. Rift Valley fever epidemic in Saudi Arabia: epidemiological, clinical, and laboratory characteristics. Clin Infect Dis 2003;37:1084-1092.
14. Burt FJ, Swanepoel R, Shieh WJ, Smith JF, Leman PA, Greer PW, Coffield LM, Rollin PE, Ksiazek TG, Peters CJ, Zaki SR. Immunohistochemical and in situ localization of Crimean-Congo hemorrhagic fever (CCHF) virus in human tissues and implications for CCHF pathogenesis. Arch Pathol Lab Med 1997;121:839-846.
15. Le Coupanec A, Babin D, Fiette L, Jouvion G, Ave P, Misse D, Bouloy M, Choumet V. Aedes mosquito saliva modulates Rift Valley fever virus pathogenicity. PLoS Negl Trop Dis 2013;7:e2237.
16. Chen XP, Cong ML, Li MH, Kang YJ, Feng YM, Plyusnin A, Xu J, Zhang YZ. Infection and pathogenesis of Huaiyangshan virus (a novel tick-borne bunyavirus) in laboratory rodents. J Gen Virol 2012;93:1288-1293.
17. Pustylnikov S, Sagar D, Jain P, Khan ZK. Targeting the C-type lectins-mediated host-pathogen interactions with dextran. J Pharm Pharm Sci 2014;17:371-392.
18. Guo Y, Feinberg H, Conroy E, Mitchell DA, Alvarez R, Blixt O, Taylor ME, Weis WI, Drickamer K. Structural basis for distinct ligand-binding and targeting properties of the receptors DC-SIGN and DC-SIGNR. Nat Struct Mol Biol 2004;11:591-598.
19. Mitchell DA, Fadden AJ, Drickamer K. A novel mechanism of carbohydrate recognition by the C-type lectins DC-SIGN and DC-SIGNR. Subunit organization and binding to multivalent ligands. J Biol Chem 2001;276:28939-28945.
20. Goncalves AR, Moraz ML, Pasquato A, Helenius A, Lozach PY, Kunz S. Role of DC-SIGN in Lassa virus entry into human dendritic cells. J Virol 2013;87:11504-11515.
21. Lozach PY, Amara A, Bartosch B, Virelizier JL, Arenzana-Seisdedos F, Cosset FL, Altmeyer R. C-type lectins L-SIGN and DC-SIGN capture and transmit infectious hepatitis C virus pseudotype particles. J Biol Chem 2004;279:32035-32045.
22. Billecocq A, Gauliard N, Le May N, Elliott RM, Flick R, Bouloy M. RNA polymerase I-mediated expression of viral RNA for the rescue of infectious virulent and avirulent Rift Valley fever viruses. Virology 2008;378:377-384.
23. Lozach PY, Lortat-Jacob H, de Lacroix de Lavalette A, Staropoli I, Foung S, Amara A, Houles C, Fieschi F, Schwartz O, Virelizier JL, Arenzana-Seisdedos F, Altmeyer R. DC-SIGN and L-SIGN are high affinity binding receptors for hepatitis C virus glycoprotein E2. J Biol Chem 2003;278:20358-20366.
24. Boulant S, Stanifer M, Lozach PY. Dynamics of virus-receptor interactions in virus binding, signaling, and endocytosis. Viruses 2015;7:2794-2815.
25. Dakappagari N, Maruyama T, Renshaw M, Tacken P, Figdor C, Torensma R, Wild MA, Wu D, Bowdish K, Kretz-Rommel A. Internalizing antibodies to the C-type lectins, L-SIGN and DC-SIGN, inhibit viral glycoprotein binding and deliver antigen to human dendritic cells for the induction of T cell responses. J Immunol 2006;176:426-440.
26. Van Breedam W, Pohlmann S, Favoreel HW, de Groot RJ, Nauwynck HJ. Bitter-sweet symphony: glycan-lectin interactions in virus biology. FEMS Microbiol Rev 2014;38:598-632.
27. Pokidysheva E, Zhang Y, Battisti AJ, Bator-Kelly CM, Chipman PR, Xiao C, Gregorio GG, Hendrickson WA, Kuhn RJ, Rossmann MG. Cryo-EM reconstruction of dengue virus in complex with the carbohydrate recognition domain of DC-SIGN. Cell 2006;124:485-493.
28. Bertolotti-Ciarlet A, Smith J, Strecker K, Paragas J, Altamura LA, McFalls JM, Frias-Staheli N, Garcia-Sastre A, Schmaljohn CS, Doms RW. Cellular localization and antigenic characterization of crimean-congo hemorrhagic fever virus glycoproteins. J Virol 2005;79:6152-6161.
29. Antic D, Wright KE, Kang CY. Maturation of Hantaan virus glycoproteins G1 and G2. Virology 1992;189:324-328.
30. Sanchez AJ, Vincent MJ, Nichol ST. Characterization of the glycoproteins of Crimean-Congo hemorrhagic fever virus. J Virol 2002;76:7263-7275.
31. Neumann AK, Thompson NL, Jacobson K. Distribution and lateral mobility of DC-SIGN on immature dendritic cells - implications for pathogen uptake. J Cell Sci 2008;121:634-643.
32. Gringhuis SI, den Dunnen J, Litjens M, van der Vlist M, Geijtenbeek TB. Carbohydrate-specific signaling through the DC-SIGN signalosome tailors immunity to Mycobacterium tuberculosis, HIV-1 and Helicobacter pylori. Nat Immunol 2009;10:1081-1088.
33. Gringhuis SI, den Dunnen J, Litjens M, van Het Hof B, van Kooyk Y, Geijtenbeek TB. C-type lectin DC-SIGN modulates Toll-like receptor signaling via Raf-1 kinase-dependent acetylation of transcription factor NF-kappaB. Immunity 2007;26:605-616.
34. Sol-Foulon N, Moris A, Nobile C, Boccaccio C, Engering A, Abastado JP, Heard JM, van Kooyk Y, Schwartz O. HIV-1 Nef-induced upregulation of DC-SIGN in dendritic cells promotes lymphocyte clustering and viral spread. Immunity 2002;16:145-155.
35. Lozach PY, Burleigh L, Staropoli I, Navarro-Sanchez E, Harriague J, Virelizier JL, Rey FA, Despres P, Arenzana-Seisdedos F, Amara A. Dendritic cell-specific intercellular adhesion molecule 3-grabbing non-integrin (DC-SIGN)-mediated enhancement of dengue virus infection is independent of DC-SIGN internalization signals. J Biol Chem 2005;280:23698-23708.
36. Braulke T, Bonifacino JS. Sorting of lysosomal proteins. Biochim Biophys Acta 2009;1793:605-614.
37. Morizono K, Chen IS. Role of phosphatidylserine receptors in enveloped virus infection. J Virol 2014;88:4275-4290.
38. Morizono K, Xie Y, Olafsen T, Lee B, Dasgupta A, Wu AM, Chen IS. The soluble serum protein Gas6 bridges virion envelope phosphatidylserine to the TAM receptor tyrosine kinase Axl to mediate viral entry. Cell Host Microbe 2011;9:286-298.
39. Meertens L, Carnec X, Lecoin MP, Ramdasi R, Guivel-Benhassine F, Lew E, Lemke G, Schwartz O, Amara A. The TIM and TAM families of phosphatidylserine receptors mediate dengue virus entry. Cell Host Microbe 2012;12:544-557.
40. Jemielity S, Wang JJ, Chan YK, Ahmed AA, Li W, Monahan S, Bu X, Farzan M, Freeman GJ, Umetsu DT, Dekruyff RH, Choe H. TIM-family proteins promote infection of multiple enveloped viruses through virion-associated phosphatidylserine. PLoS Pathog 2013;9:e1003232.
41. Tabarani G, Thepaut M, Stroebel D, Ebel C, Vives C, Vachette P, Durand D, Fieschi F. DC-SIGN neck domain is a pH-sensor controlling oligomerization: SAXS and hydrodynamic studies of extracellular domain. J Biol Chem 2009;284:21229-21240.
42. Gramberg T, Soilleux E, Fisch T, Lalor PF, Hofmann H, Wheeldon S, Cotterill A, Wegele A, Winkler T, Adams DH, Pohlmann S. Interactions of LSECtin and DC-SIGN/DC-SIGNR with viral ligands: differential pH dependence, internalization and virion binding. Virology 2008;373:189-201.
43. Probert F, Mitchell DA, Dixon AM. NMR evidence for oligosaccharide release from the dendritic-cell specific intercellular adhesion molecule 3-grabbing non-integrin-related (CLEC4M) carbohydrate recognition domain at low pH. FEBS J 2014;281:3739-3750.
44. Burleigh L, Lozach PY, Schiffer C, Staropoli I, Pezo V, Porrot F, Canque B, Virelizier JL, Arenzana-Seisdedos F, Amara A. Infection of dendritic cells (DCs), not DC-SIGN-mediated internalization of human immunodeficiency virus, is required for long-term transfer of virus to T cells. J Virol 2006;80:2949-2957.
45. Giorgi C, Accardi L, Nicoletti L, Gro MC, Takehara K, Hilditch C, Morikawa S, Bishop DH. Sequences and coding strategies of the S RNAs of Toscana and Rift Valley fever viruses compared to those of Punta Toro, Sicilian Sandfly fever, and Uukuniemi viruses. Virology 1991;180:738-753.
46. Laughlin LW, Meegan JM, Strausbaugh LJ, Morens DM, Watten RH. Epidemic Rift Valley fever in Egypt: observations of the spectrum of human illness. Trans R Soc Trop Med Hyg 1979;73:630-633.
47. Pettersson R, Kaariainen L. The ribonucleic acids of Uukuniemi virus, a noncubical tick-borne arbovirus. Virology 1973;56:608-619.
48. Billecocq A, Vialat P, Bouloy M. Persistent infection of mammalian cells by Rift Valley fever virus. J Gen Virol 1996;77:3053-3062.
49. Persson R, Pettersson RF. Formation and intracellular transport of a heterodimeric viral spike protein complex. J Cell Biol 1991;112:257-266.
50. Meier R, Franceschini A, Horvath P, Tetard M, Mancini R, von Mering C, Helenius A, Lozach PY. Genome-wide small interfering RNA screens reveal VAMP3 as a novel host factor required for Uukuniemi virus late penetration. J Virol 2014;88:8565-8578.